These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2554792)
1. Protease nexin I immunostaining in Alzheimer's disease. Rosenblatt DE; Geula C; Mesulam MM Ann Neurol; 1989 Nov; 26(5):628-34. PubMed ID: 2554792 [TBL] [Abstract][Full Text] [Related]
2. Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody. Ikeda S; Allsop D; Glenner GG Lab Invest; 1989 Jan; 60(1):113-22. PubMed ID: 2642985 [TBL] [Abstract][Full Text] [Related]
3. Neurofibrillary tangles in some cases of dementia pugilistica share antigens with amyloid beta-protein of Alzheimer's disease. Allsop D; Haga S; Bruton C; Ishii T; Roberts GW Am J Pathol; 1990 Feb; 136(2):255-60. PubMed ID: 2407121 [TBL] [Abstract][Full Text] [Related]
4. Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor. Van Nostrand WE; Wagner SL; Suzuki M; Choi BH; Farrow JS; Geddes JW; Cotman CW; Cunningham DD Nature; 1989 Oct; 341(6242):546-9. PubMed ID: 2507928 [TBL] [Abstract][Full Text] [Related]
5. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Tanzi RE; McClatchey AI; Lamperti ED; Villa-Komaroff L; Gusella JF; Neve RL Nature; 1988 Feb; 331(6156):528-30. PubMed ID: 2893290 [TBL] [Abstract][Full Text] [Related]
6. Immunogold labeling of cerebrovascular and neuritic plaque amyloid fibrils in Alzheimer's disease with an anti-beta protein monoclonal antibody. Ikeda S; Wong CW; Allsop D; Landon M; Kidd M; Glenner GG Lab Invest; 1987 Oct; 57(4):446-9. PubMed ID: 3312810 [TBL] [Abstract][Full Text] [Related]
7. [Proteins, genes and early diagnosis of Alzheimer's disease]. Laplanche JL; Chatelain J; Launay JM; Dreux C Ann Biol Clin (Paris); 1990; 48(5):281-5. PubMed ID: 2195924 [TBL] [Abstract][Full Text] [Related]
8. Protein abnormalities in neurofibrillary tangles: their relation to the extracellular amyloid deposits of the A4 protein in Alzheimer's disease. Masters CL; Beyreuther K Adv Neurol; 1990; 51():151-61. PubMed ID: 1967195 [No Abstract] [Full Text] [Related]
9. [Importance of neurofibrillary degeneration in the diagnosis of Alzheimer's disease]. Gómez-Ramos P; Jiménez A; Cebrián JL; Morán MA Med Clin (Barc); 1993 Jun; 101(2):60-3. PubMed ID: 8510479 [TBL] [Abstract][Full Text] [Related]
10. Plaque-associated neuronal proteins: a recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain. Schmidt ML; DiDario AG; Otvos L; Hoshi N; Kant JA; Lee VM; Trojanowski JQ Exp Neurol; 1994 Dec; 130(2):311-22. PubMed ID: 7867760 [TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease therapeutics: new approaches to an ageing problem. Small DH; Losic D; Martin LL; Turner BJ; Friedhuber A; Aguilar MI IUBMB Life; 2004 Apr; 56(4):203-8. PubMed ID: 15230347 [TBL] [Abstract][Full Text] [Related]
12. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Padmanabhan J; Levy M; Dickson DW; Potter H Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932 [TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain. Fabbro S; Seeds NW J Neurochem; 2009 Apr; 109(2):303-15. PubMed ID: 19222708 [TBL] [Abstract][Full Text] [Related]
14. Immunodetection of cathepsin D in neuritic plaques found in brains of patients with dementia of Alzheimer type. Bernstein HG; Bruszis S; Schmidt D; Wiederanders B; Dorn A J Hirnforsch; 1989; 30(5):613-8. PubMed ID: 2558133 [TBL] [Abstract][Full Text] [Related]
15. APP with Kunitz type protease inhibitor domain (KPI) correlates with neuritic plaque density but not with cortical synaptophysin immunoreactivity in Alzheimer's disease and non-demented aged subjects: a multifactorial analysis. Zhan SS; Sandbrink R; Beyreuther K; Schmitt HP Clin Neuropathol; 1995; 14(3):142-9. PubMed ID: 7671455 [TBL] [Abstract][Full Text] [Related]
16. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Snow AD; Mar H; Nochlin D; Kimata K; Kato M; Suzuki S; Hassell J; Wight TN Am J Pathol; 1988 Dec; 133(3):456-63. PubMed ID: 2974240 [TBL] [Abstract][Full Text] [Related]
17. The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition. Tabaton M; Mandybur TI; Perry G; Onorato M; Autilio-Gambetti L; Gambetti P Ann Neurol; 1989 Dec; 26(6):771-8. PubMed ID: 2557796 [TBL] [Abstract][Full Text] [Related]
18. The second layer neurones of the entorhinal cortex and the perforant path in physiological ageing and Alzheimer's disease. Moryś J; Sadowski M; Barcikowska M; Maciejewska B; Narkiewicz O Acta Neurobiol Exp (Wars); 1994; 54(1):47-53. PubMed ID: 8023713 [TBL] [Abstract][Full Text] [Related]
19. Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles. Mesulam MM; Geula C; Morán MA Ann Neurol; 1987 Dec; 22(6):683-91. PubMed ID: 3435078 [TBL] [Abstract][Full Text] [Related]